Although genetic engineers have ways to direct molecular evolution in the laboratory, they can usually only test many possibilities. And even a typical long protein can be changed in an almost infinite way (because it is built from hundreds of amino acids, and each acid comes in 20 possible varieties). However, OpenAI models often suggest that a third of the amino acids in a protein should be replaced. OPENAI “We immediately threw this model into the laboratory and got real results,” said Retro CEO, Joe Betts-Lacroix. He said that the model idea was very good, leading to improvements over the original Yamanaka factor in some cases. Vadim Gladyshev, a Harvard University senior researcher who consults with Retro, said that a better way to create stem cells is needed. “For us, it will be very useful. [Skin cells] easy to reprogram, but other cells are not,” he said. “And to do it in a new species – often very different, and you get nothing.” How exactly GPT-4b arrived at its guess is still not clear-as is often the case with “It’s like when AlphaGo is the best at Go, but it’s taking a long time to figure out what’s going on,” says Betts-Lacroix said that no money changed hands in the But since the work could benefit Retro — whose biggest investor is Altman — the announcement may raise questions about the OpenAI CEO’s side project. Last year, the Wall Street Journal said Altman’s investment in the private tech startup was an obscure investment empire” that “creates a list of potential conflicts,” because some of these companies also do business with OpenAI. In the case of Retro, only associated with Altman, OpenAI, and the race to AGI can increase the profile and increase the ability to hire staff and collect funds. Betts-Lacroix did not respond to questions about whether the early-stage company is currently in fundraising mode. OpenAI said Altman was not directly involved in the work and never made decisions based on Altman’s other investments.
